Valeritas to Host Conference Call with Clinical Experts to Discuss their Treatment of Patients with Type 2 Diabetes and V-Go® on May 18, 2017

BRIDGEWATER, N.J., May 03, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that the Company will host a conference call with clinical experts to discuss their treatment of patients with diabetes and the V-Go Wearable Insulin Delivery device. The call with feature David Sutton, M.D., and John Sink, PA-C, CDE, and will be moderated by Greg Chodaczek, senior medical technology research analyst at B. Riley Financial.

     Event:   V-Go Wearable Insulin Delivery Device Clinical Expert Panel  
  
     Date:    Thursday, May 18, 2017 
 
     Time:    11:30 a.m. EDT

The dial-in numbers for the call are (877) 201-0168 for domestic callers and (647) 788-4901 for international callers. The conference ID number is 12173700. A live webcast of the conference call will be available on the investor relations page of the Valeritas corporate website at www.valeritas.com.

A telephonic replay of the call will be available by dialing (800) 585-8367 for domestic callers and (416) 621-4642 for international callers. Please use the replay pin number 12173700. The webcast will also be archived on the investor relations page of the company’s website.

Participating Physicians

David Sutton, MD, is a cofounder of the Northeast Florida Endocrine and Diabetes Association (NEFEDA), the largest private practice endocrine group in the United States. Together, NEFEDA physicians cover seven hospitals in the Jacksonville, Florida, area and manage more than 50,000 patients with diabetes. Dr. Sutton is also Chief of Endocrine at both Baptist Medical Center and St Vincent’s Hospital in Jacksonville. He is an active member of the Endocrine Society and a fellow with the American Association of Clinical Endocrinologists. He is also actively involved locally with both the Juvenile Diabetes Research Foundation and the American Diabetes Association. Dr. Sutton earned his doctor of medicine from Wake Forest University and completed his residency at the University of Florida Health and Science Center.

John Sink, PA-C, CDA, is a Physician Assistant at The Jones Center for Diabetes and Endocrine Wellness in Macon, GA. Mr. Sink is a Certified Diabetes Educator (2001) as well as a Clinical Lipid Specialist. He is a Fellow of the AAPA and GAPA and one of the first Physician Assistants accepted as Fellow of the National Lipid Association. He also currently serves as the Treasurer for the American Society of Endocrine PAs and Board Member at large for the Accreditation Council for Clinical Lipidology. Mr. Sink received his undergraduate degree from Macon College and went on to get a Bachelor of Science degree from Georgia College & State University. He graduated Summa Cum Laude with a Bachelor of Science in Physician Assistant from the Medical College of Georgia in 1998.

About Valeritas Holdings, Inc.

Valeritas is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas’ flagship product, V-Go^® Wearable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery device for patients with type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides discreet on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.

Investor Contacts:
Nick Laudico / Robert Flamm, Ph.D.
The Ruth Group
(646)536-7030 / 7017
[email protected]

Or

The Del Mar Consulting Group, Inc.
Robert B. Prag, President
858-794-9500
[email protected]

Media Contact:
Kirsten Thomas
The Ruth Group
(508)280-6592
[email protected]